KANDICE BURK: Open Payments
NPI 1902371925 · KINGFISHER, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 31 payments from 14 companies in 2025. Trend: 2023 $460 · 2024 $298 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $137 |
| Janssen Pharmaceuticals, Inc | 1 | $124 |
| Insulet Corporation | 4 | $82 |
| Exact Sciences Corporation | 4 | $68 |
| Novo Nordisk Inc | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Lilly USA, LLC | 2 | $28 |
| Lundbeck LLC | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: SPRAVATO, AIRSUPRA, Omnipod, The Cologuard Plus Collection Kit, REXULTI, Ozempic, CAPLYTA, MOUNJARO.
Industry payments across OK — which companies pay providers there.
